Calliditas Therapeutics AB Sponsored ADR Gross Profit 2020-2024 | CALT
Calliditas Therapeutics AB Sponsored ADR gross profit from 2020 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Calliditas Therapeutics AB Sponsored ADR Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $108 |
| 2022 | $78 |
| 2021 | $27 |
| 2020 | $0 |
| 2019 | $20 |
| Calliditas Therapeutics AB Sponsored ADR Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-06-30 | $47 |
| 2024-03-31 | $27 |
| 2023-12-31 | $41 |
| 2023-09-30 | $26 |
| 2023-06-30 | $24 |
| 2023-03-31 | $17 |
| 2022-12-31 | $42 |
| 2022-09-30 | $24 |
| 2022-06-30 | $6 |
| 2022-03-31 | $5 |
| 2021-12-31 | $4 |
| 2021-09-30 | $23 |
| 2021-06-30 | |
| 2021-03-31 | |
| 2020-12-31 | $0 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | $0 |
| 2019-12-31 | $5 |
| 2019-09-30 | |
| 2019-06-30 | $15 |
| 2019-03-31 | |
